Cat.#: ACPP-1637
Despition | NRN1 Human Recombinant, His |
SIZE | 2 µg |
Purity | Purity as determined by densitometric image analysis is > 95%. |
Form | Filtered White lyophilized (freeze-dried) powder. |
Storage | Lyophilized was stored at -20°C to -80°C, while reconstituted was aliquot and stored at -80°C. Avoid freeze/thaw cycles. |
Shipping | Shipped at 4°C |
Citation Guidance | If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. |
Cat.# | Name | Size | Price |
---|---|---|---|
ACPP-1769 | Human VAT1 Protein (AC1769) | 2 µg | inquiry |
ACPP-1256 | Bestrophin Blocking Peptide (AC1256) | 250 µg | inquiry |
ACPP-1273 | BTB/POZ domain-containing protein 7 Blocking Peptide (AC1273) | 250 µg | inquiry |
ACPP-1570 | Human Acrp30 Protein, Trimeric (AC1570) | 2 µg | inquiry |
ACPP-1814 | PPA E.Coli (AC1814) | 5 µg | inquiry |
ACPP-1100 | Synthetic Membrane Nanoparticle Human Somatostatin Receptor 2 Protein (AC1100) | 50 µg | inquiry |
ACPP-1556 | Human SMARCA4 Protein (AC1556) | 5 µg | inquiry |
ACPP-1218 | Dopamine D2 Receptor Blocking Peptide (AC1218) | 250 µg | inquiry |
ACPP-1163 | Recombinant Human GFAP Protein (Fc Tag) (AC1163) | 50 µg | inquiry |
ACPP-1250 | Lin28 Blocking Peptide (AC1250) | 250 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.